Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 4/20 | 0.41 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CTSS | P25774 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 6/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15341460 | 0.98 | EPHX1 (0.46) | EPHX1CTSKCA12CA1CA7 | |
| SCHEMBL7527615 | 0.98 | EPHX1 (0.46) | EPHX1CTSKCA12CA1CA7 | |
| SCHEMBL1865098 | 0.94 | CTSK (0.42) | CTSKCA12CA1CA7CA14 | |
| SCHEMBL20464123 | 0.86 | CA1 (0.43) | CTSKCA12CA1CA7CA14 | |
| SCHEMBL3486538 | 0.85 | CA1 (0.40) | CTSKCA12CA1CA7CA14 | |
| SCHEMBL755597 | 0.85 | CA1 (0.40) | CA12CA1CA7CA14CA2 | |
| SCHEMBL11496116 | 0.84 | CA1 (0.39) | CTSKCA12CA1CA7CA14 | |
| SCHEMBL5493650 | 0.84 | TDP1 (0.59) | CA12CA1CA7CA2CA9 | |
| SCHEMBL5498803 | 0.84 | TDP1 (0.42) | CA12CA1CA7CA14CA2 | |
| SCHEMBL13225165 | 0.83 | CASP2 (0.45) | CA12CA1CA2CA9TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108699558-A | nucleic acid complexes | 协和发酵麒麟株式会社 | 2018-10-23 | — | — | CN | disclosed |
| CN-101855258-B | Microphase separated structure film and process for producing the microphase separated structure film | NAT UNIV CORP TOKYO INST TECHNOLOGY | 2013-07-10 | — | — | CN | disclosed |
| US-8466176-B2 | Fungicide hydroximoyl-tetrazole derivatives | BAYER CROPSCIENCE AG (DE) | 2013-06-18 | — | — | US | disclosed |
| US-20110105566-A1 | FUNGICIDE HYDROXIMOYL-TETRAZOLE DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2011-05-05 | — | — | US | disclosed |
| CN-101855258-A | Microphase separated structure film and process for producing the microphase separated structure film | TOYOTA JIDOSYA KABUSHIKI KAISHA | 2010-10-06 | — | — | CN | disclosed |
| US-20080113924-A1 | Neuramindase Inhibitor | NATIONAL INSTITUE OF ADVANCE INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2008-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105566-A1 | FUNGICIDE HYDROXIMOYL-TETRAZOLE DERIVATIVES | HAAO, CYP51A1, HPD | EPHX1 1130/4885CTSK 1530/4885CA12 1447/4885 |
| US-20080113924-A1 | Neuramindase Inhibitor | NMBR, NEU1, NMUR1 | EPHX1 1102/4885CTSK 1293/4885CA12 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.